Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities
−Removed: Owens & Minor, Inc.’s common stock trades on the New York Stock Exchange under the symbol OMI.
+Added: Accendra Health, Inc.’s common stock trades on the New York Stock Exchange under the symbol ACH (formerly OMI).
As of January 31, 2026, there were 1,772 common shareholders of record.
1 unchanged sentence
5-Year Total Shareholder Return
−Removed: The following performance graph compares the performance of our common stock to the Standard & Poor’s Composite-500 Index (S&P 500 Index), the Russell 3000 Medical Equipment and Services Sector Index, an index that includes more than 100 companies in the medical equipment and services industry.
+Added: The following performance graph compares the performance of our common stock to the Russell 2000 Index and the Russell 3000 Medical Equipment and Services Sector Index, an index that includes more than 100 companies in the medical equipment and services industry.
This graph assumes that the value of the investment in the common stock and each index was $100 on December 31, 2020, and that all dividends were reinvested.
Company Name / Index
−Removed: Owens & Minor, Inc.
−Removed: S&P 500 Index
+Added: Accendra Health, Inc.
+Added: Russell 2000 Index
Russell 3000 Medical Equipment and Services Sector
−Removed: On February 26, 2025, the Owens & Minor Board of Directors authorized a share repurchase program of up to $100 million over the next 24 months.
−Removed: Under the program, Owens & Minor may repurchase shares of common stock on a discretionary basis from time to time through open market repurchases, privately negotiated transactions and 10b5-1 trading plans.
+Added: On February 26, 2025, our Board of Directors authorized a share repurchase program of up to $100 million and expires in February 2027.
+Added: Under the program, we may repurchase shares of common stock on a discretionary basis from time to time through open market repurchases, privately negotiated transactions and 10b5-1 trading plans.
+Added: The following table summarizes share repurchase activity for the year ended December 31, 2025:
+Added: (in thousands, except per share data)
+Added: Total Number of Shares Purchased
+Added: Average Price Paid Per Share
+Added: Total Number of Shares Purchased as Part of Publicly Announced Program (1)
+Added: Approximate Dollar Value of Shares That May Yet be Purchased Under the Program (2)
+Added: February 26-February 28, 2025
+Added: March 1-March 31, 2025
+Added: April 1-April 30, 2025
+Added: May 1-May 31, 2025
+Added: June 1-June 30, 2025
+Added: July 1-July 31, 2025
+Added: August 1-August 31, 2025
+Added: September 1-September 30, 2025
+Added: October 1-October 31, 2025
+Added: November 1-November 30, 2025
+Added: December 1-December 31, 2025
+Added: (1) On February 26, 2025, our Board of Directors authorized a share repurchase program of up to $100 million.
+Added: The program expires in February 2027.
+Added: Under the program, we may repurchase shares of common stock on a discretionary basis from time to time through open market repurchases, privately negotiated transactions and 10b5-1 trading plans.
+Added: (2) During the period from February 26, 2025 (the date the share repurchase program was authorized) through December 31, 2025, we repurchased shares in open-market transactions and retired approximately 2.0 million shares of our common stock for an aggregate of $10 million, or a weighted average price per share of $5.19.
+Added: (3) Represents the period from February 26, 2025 (the date the share repurchase program was authorized) through December 31, 2025.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.